BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22305496)

  • 21. C-reactive protein predicts short-term mortality in patients with cirrhosis.
    Cervoni JP; Thévenot T; Weil D; Muel E; Barbot O; Sheppard F; Monnet E; Di Martino V
    J Hepatol; 2012 Jun; 56(6):1299-304. PubMed ID: 22314431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices.
    Dong TS; Kalani A; Aby ES; Le L; Luu K; Hauer M; Kamath R; Lindor KD; Tabibian JH
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1894-1901.e1. PubMed ID: 30708109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension.
    Nguyen GC; Segev DL; Thuluvath PJ
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1092-9. PubMed ID: 17625983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severity of Systemic Inflammatory Response Syndrome Affects Outcomes in Decompensated Cirrhotics with Spontaneous Bacterial Peritonitis.
    Twilla JD; Nair SP; Talwar M; Kovalic A; Satapathy SK
    Am J Gastroenterol; 2016 Jul; 111(7):1043-5. PubMed ID: 27356838
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.
    Merli M; Lucidi C; Pentassuglio I; Giannelli V; Giusto M; Di Gregorio V; Pasquale C; Nardelli S; Lattanzi B; Venditti M; Riggio O
    J Hepatol; 2013 Aug; 59(2):243-50. PubMed ID: 23523580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis.
    Kwon JH; Jang JW; Kim YW; Lee SW; Nam SW; Jaegal D; Lee S; Bae SH
    BMC Gastroenterol; 2015 Oct; 15():146. PubMed ID: 26498833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver.
    Lux G; Retterspitz M; Stabenow-Lohbauer U; Langer M; Altendorf-Hofmann A; Bozkurt T
    Endoscopy; 1997 May; 29(4):241-6. PubMed ID: 9255525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices.
    Park DK; Um SH; Lee JW; Lee JB; Kim YS; Park CH; Jin YT; Chun HJ; Lee HS; Lee SW; Choi JH; Kim CD; Ryu HS; Hyun JH
    J Gastroenterol Hepatol; 2004 Sep; 19(9):1042-51. PubMed ID: 15304123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Factors participating in development of bleeding varices in portal hypertension. Part I: bacterial infection and comparison of intravenous and peroral antibiotics effects--a randomised study].
    Lata J; Juránková J; Husová L; Senkyrík M; Díte P; Dastych M; Príbramská V
    Vnitr Lek; 2004 Nov; 50(11):830-5. PubMed ID: 15648962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognosis of hepatic cirrhosis in relation to clinical and biological parameters and the degree of portal hypertension].
    González Reyes A; González Reimers CE; Santolaria Fernández F; Hernández García MT; Pestana Pestana M; Batista López N; Jorge Hernández JA; Cubillo Ferreira G; Hernández Nieto L
    Rev Esp Enferm Apar Dig; 1987 Apr; 71(4):286-92. PubMed ID: 3496633
    [No Abstract]   [Full Text] [Related]  

  • 33. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
    D'Amico G; Morabito A; D'Amico M; Pasta L; Malizia G; Rebora P; Valsecchi MG
    Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
    Sharma P; Kumar A; Sharma BC; Sarin SK
    J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of upper gastrointestinal endoscopy in evaluation of portal hypertension].
    Melinte-Popescu M; Bălan G
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1003-6. PubMed ID: 22276436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels.
    Kondo M; Miszputen SJ; Leite-mor MM; Parise ER
    Hepatogastroenterology; 1995; 42(5):542-5. PubMed ID: 8751212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
    Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
    Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Portal hypertension in cirrhoses: mechanisms, symptomatology and complications].
    Buffet C
    Rev Prat; 1990 Jun; 40(16):1454-7. PubMed ID: 2359944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.